Historique de carrière de Micah Zajic
Anciens postes connus de Micah Zajic
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LEXEO THERAPEUTICS, INC. | Directeur Financier/CFO | 01/01/2023 | 01/07/2023 |
| Corporate Officer/Principal | 01/07/2023 | 31/12/2023 | |
| SQZ BIOTECHNOLOGIES COMPANY | Directeur Financier/CFO | 11/07/2022 | 31/12/2022 |
| Corporate Officer/Principal | 16/09/2020 | 11/07/2022 | |
MeiraGTx Ltd.
 MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/04/2017 | 01/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2014 | 01/04/2017 |
Formation de Micah Zajic
| Georgetown University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| LEXEO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Micah Zajic
- Expérience
